| Products | Pharmacopoeia |
| Calcium Glycerophosphate | BP/ EP/ BPC 63 / 50% W/W solution |
| Magnesium Glycerophosphate | BP / EP / BPC 63 |
| Sodium Glycerophosphate | BP (Hydrated)/ BPC 49 / 50% solution BPC 63 |
| Manganese Glycerophosphate | EP (Hydrated)/ NF 10 |
| Potassium Glycerophosphate | 50% solution BPC 63 / 70% W/W solution (In-house) / 75% W/W solution (In-house) |
| Ferric Glycerophosphate | BPC 63 (In-house) |
| Zinc Glycerophosphate | In-house |
| Glycerophosphoric Acid | 20% solution BPC 63 / 35% W/W solution (In-house) / 50% W/W solution (In-house) |
| Calcium Bromo Lactobionate | In-house |
| Calcium Glucoheptonate | BP |
| Calcium Levulinate | IP / BP / EP / USP |
| Sodium Levulinate | In-house |
| Tolbutamide | IP / BP / USP |
Bihani Chemical Industries’ business commitment to certification and quality is of the highest priority. Our production facility is cGMP compliant and adheres to global quality manufacturing requirements. Our facilities are currently under the process of expanding to compliance of European DMF and Certificate of Suitability for its selective products.
Our entire product range is manufactured to meet the highest quality standards and conforms to the following specifications :
1) British Pharmacopoeia (BP).
2) British Pharmaceutical Codex (BPC)
3) European Pharmacopoeia (EP)
4) Indian Pharmacopoeia (IP)
5) United StatesPharmacopoeia (USP)
We support all product enquiries and sales with extensive quality documentation that include :
a) Typical & batch-to-batch Certificate of Analysis (C.O.A)
b) Material Safety Data Sheet (MSDS)
c) Method of Analysis
d) Analytical Specifications (AS)
e) Drug Master File in CTD Format
Bihani Chemical Industries works with its clients towards their respective Drug Authority Certification requirements and FCC product compliance, thereby ensuring a faster turnaround time in taking products to market.
